These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7431711)

  • 21. Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer.
    Fong L; Ruegg CL; Brockstedt D; Engleman EG; Laus R
    J Immunol; 1997 Oct; 159(7):3113-7. PubMed ID: 9317107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunofluorescent identification of antibodies specific for prostatic acid phosphatase.
    Ablin RJ
    Pathology; 1981 Oct; 13(4):681-4. PubMed ID: 7038603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fundamental and clinical study of PAP 'Eiken' (author's transl)].
    Higuchi Y; Kida T
    Kaku Igaku; 1981 Dec; 18(10):1451-7. PubMed ID: 6176743
    [No Abstract]   [Full Text] [Related]  

  • 24. The preparation, characterization and application of monoclonal antibodies to human prostatic acid phosphatase (PAP).
    Sturgeon CM; Micklem LR; Hussey AJ; Seth J; Scott A; Ritchie AW; Chisholm GD; James K
    Dev Biol Stand; 1984; 57():331-40. PubMed ID: 6084620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody (anti-Leu 7) directed against natural killer cells reacts with normal, benign and malignant prostate tissues.
    Wahab ZA; Wright GL
    Int J Cancer; 1985 Dec; 36(6):677-83. PubMed ID: 2415469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).
    Johnson LE; Frye TP; Arnot AR; Marquette C; Couture LA; Gendron-Fitzpatrick A; McNeel DG
    Vaccine; 2006 Jan; 24(3):293-303. PubMed ID: 16115700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemistry of prostatic acid phosphatase.
    Yam LT; Janckila AJ; Lam WK; Li CY
    Prostate; 1981; 2(1):97-107. PubMed ID: 7024961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on human prostatic acid phosphatase. IV. Stabilization of prostatic acid phosphatase against thermal inactivation by the homologous antibody.
    Sawada H; Maruyama H; Sengoku H; Nakayama T
    Chem Pharm Bull (Tokyo); 1981 Oct; 29(10):2934-9. PubMed ID: 7318023
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of antisera to prostatic acid phosphatase for the identification of cultured human cells.
    Rose NR; Pontes JE; Choe BK
    Natl Cancer Inst Monogr; 1978 Dec; (49):29-30. PubMed ID: 372821
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunoenzyme assay for human prostatic acid phosphatase.
    Choe BK; Rose NR; Korol M; Pontes EJ
    Proc Soc Exp Biol Med; 1979 Dec; 162(3):396-400. PubMed ID: 390535
    [No Abstract]   [Full Text] [Related]  

  • 31. [Are serum acid phosphatase levels of diagnostic significance in prostatic cancer? (author's transl)].
    Bollack C; Helwig JJ; Offner M
    Sem Hop; 1979 Dec 18-25; 55(43-44):2022-6. PubMed ID: 233445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal anti-human prostatic acid phosphatase antibodies.
    Lillehoj HS; Choe BK; Rose NR
    Mol Immunol; 1982 Sep; 19(9):1199-202. PubMed ID: 6183581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-affinity monoclonal antibodies specific for human prostatic acid phosphatase.
    Höyhtyä M; Vihko P; Vuolas L; Tryggvason K; Vihko R
    Clin Chem; 1987 Jan; 33(1):103-7. PubMed ID: 3100092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A solid-phase radioimmunoassay for human prostatic acid phosphatase.
    Foti AG; Herschman H; Cooper JF
    Cancer Res; 1975 Sep; 35(9):2446-52. PubMed ID: 1170944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic studies of normal, benign, and malignant human prostatic tissue.
    Ablin RJ
    Cancer; 1972 Jun; 29(6):1570-4. PubMed ID: 4624168
    [No Abstract]   [Full Text] [Related]  

  • 36. A solid-phase fluorescent immunoassay for human prostatic acid phosphatase.
    Lee CI; Wang MC; Murphy GP; Chu TM
    Cancer Res; 1978 Sep; 38(9):2871-8. PubMed ID: 354781
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunologic markers and the diagnosis of prostatic cancer.
    Ban Y; Wang MC; Chu TM
    Urol Clin North Am; 1984 May; 11(2):269-76. PubMed ID: 6203206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase.
    Goldenberg DM; DeLand FH
    Urol Clin North Am; 1984 May; 11(2):277-81. PubMed ID: 6328719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioimmunodetection of prostatic cancer. In vivo use of radioactive antibodies against prostatic acid phosphatase for diagnosis and detection of prostatic cancer by nuclear imaging.
    Goldenberg DM; DeLand FH; Bennett SJ; Primus FJ; Nelson MO; Flanigan RC; McRoberts JW; Bruce AW; Mahan DE
    JAMA; 1983 Aug; 250(5):630-5. PubMed ID: 6345831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunochemical identification of prostatic tissue-specific acid phosphatase.
    Ablin RJ
    Clin Chem; 1973 Jul; 19(7):786-8. PubMed ID: 4197248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.